These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23032684)

  • 41. Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways.
    Gimba ER; Tilli TM
    Cancer Lett; 2013 Apr; 331(1):11-7. PubMed ID: 23246372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Somatostatin receptors and regulation of cell proliferation.
    Bousquet C; Guillermet J; Vernejoul F; Lahlou H; Buscail L; Susini C
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S2-7. PubMed ID: 15077905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variants of G protein-coupled receptors: a reappraisal of their role in receptor regulation.
    Maggio R; Fasciani I; Rossi M; Di Gregorio J; Pietrantoni I; Puca V; Flati V; Scarselli M
    Biochem Soc Trans; 2016 Apr; 44(2):589-94. PubMed ID: 27068974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types.
    Del Rio-Moreno M; Alors-Perez E; Borges de Souza P; Prados-Gonzalez ME; CastaÑo JP; Luque RM; Gahete MD
    Transl Res; 2019 Sep; 211():147-160. PubMed ID: 30904441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies.
    Werner C; Dirsch O; Dahmen U; Grimm MO; Schulz S; Lupp A
    Transl Oncol; 2020 Sep; 13(9):100801. PubMed ID: 32460182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors.
    Florio T; Schettini G
    J Mol Endocrinol; 1996 Oct; 17(2):89-100. PubMed ID: 8938584
    [No Abstract]   [Full Text] [Related]  

  • 47. Somatostatinergic systems: an update on brain functions in normal and pathological aging.
    Martel G; Dutar P; Epelbaum J; Viollet C
    Front Endocrinol (Lausanne); 2012; 3():154. PubMed ID: 23230430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The elucidation of somatostatin receptor functions: a current view.
    Meyerhof W
    Rev Physiol Biochem Pharmacol; 1998; 133():55-108. PubMed ID: 9600011
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibitory effect of truncated isoforms on GPCR dimerization predicted by combinatorial computational strategy.
    Li M; Qing R; Tao F; Xu P; Zhang S
    Comput Struct Biotechnol J; 2024 Dec; 23():278-286. PubMed ID: 38173876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of Concern: Specific roles of Gi protein family members revealed by dissecting SST5 coupling in human pituitary cells.
    Peverelli E; Busnelli M; Vitali E; Giardino E; Galés C; Lania AG; Beck-Peccoz P; Chini B; Mantovani G; Spada A
    J Cell Sci; 2022 Nov; 135(22):. PubMed ID: 36441052
    [No Abstract]   [Full Text] [Related]  

  • 51. Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST
    Pedraza-Arevalo S; Ibáñez-Costa A; Blázquez-Encinas R; Branco MR; Vázquez-Borrego MC; Herrera-Martínez AD; Venegas-Moreno E; Serrano-Blanch R; Arjona-Sánchez Á; Gálvez-Moreno MA; Korbonits M; Soto-Moreno A; Gahete MD; Charalambous M; Luque RM; Castaño JP
    Mol Oncol; 2022 Feb; 16(3):764-779. PubMed ID: 34601790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.
    Peverelli E; Treppiedi D; Mangili F; Catalano R; Spada A; Mantovani G
    Nat Rev Endocrinol; 2021 Sep; 17(9):560-571. PubMed ID: 34194011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central somatostatin signaling and regulation of food intake.
    Stengel A; Taché Y
    Ann N Y Acad Sci; 2019 Nov; 1455(1):98-104. PubMed ID: 31237362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.
    Günther T; Tulipano G; Dournaud P; Bousquet C; Csaba Z; Kreienkamp HJ; Lupp A; Korbonits M; Castaño JP; Wester HJ; Culler M; Melmed S; Schulz S
    Pharmacol Rev; 2018 Oct; 70(4):763-835. PubMed ID: 30232095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response.
    Stengel A; Taché YF
    Front Neurosci; 2017; 11():231. PubMed ID: 28487631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line.
    Cambiaghi V; Vitali E; Morone D; Peverelli E; Spada A; Mantovani G; Lania AG
    Endocrine; 2017 Apr; 56(1):146-157. PubMed ID: 27406390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells.
    Molè D; Gentilin E; Ibañez-Costa A; Gagliano T; Gahete MD; Tagliati F; Rossi R; Pelizzo MR; Pansini G; Luque RM; Castaño JP; degli Uberti E; Zatelli MC
    Endocrine; 2015 Nov; 50(2):442-52. PubMed ID: 25854304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Truncated variants of pig somatostatin receptor subtype 5 (sst5) act as dominant-negative modulators for sst2-mediated signaling.
    Durán-Prado M; Gahete MD; Delgado-Niebla E; Martínez-Fuentes AJ; Vázquez-Martínez R; García-Navarro S; Gracia-Navarro F; Malagon MM; Luque RM; Castaño JP
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(11):E1325-34. PubMed ID: 23032684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology.
    Córdoba-Chacón J; Gahete MD; Durán-Prado M; Luque RM; Castaño JP
    Ann N Y Acad Sci; 2011 Mar; 1220():6-15. PubMed ID: 21388399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors.
    Durán-Prado M; Gahete MD; Martínez-Fuentes AJ; Luque RM; Quintero A; Webb SM; Benito-López P; Leal A; Schulz S; Gracia-Navarro F; Malagón MM; Castaño JP
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2634-43. PubMed ID: 19401364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.